Axsome Therapeutics, Inc.

This study aimed to see if the drug AXS-05 is safe and effective for long-term use in adults with major depression that hasn't improved with other treatments. It involved 181 participants at multiple locations. The trial was open-label, meaning both the participants and doctors k…

This study aimed to check the long-term safety of AXS-05 for treating agitation in people with Alzheimer's disease. It included 139 participants who had completed previous trials of the same medication. The trial was terminated, meaning it ended early before reaching its planned …